OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

Sanofi SA/  FR0000120578  /

Euronext - Paris
3/24/2023  5:39:18 PM Chg. +1.26 Volume Bid5:40:00 PM Ask5:40:00 PM Market Capitalization Dividend Y. P/E Ratio
97.10EUR +1.31% 2.73 mill.
Turnover: 263.42 mill.		 96.00Bid Size: 156 97.11Ask Size: 200 121.62 bill.EUR 3.43% 19.54
TeleTrader 3/13 Sanofi to acquire Provention Bio for $2.9 billion
TeleTrader 2/3 Sanofi Q4 net sales up 7.3% to €10.73 billion
TeleTrader 1/13 J&J reportedly cuts COVID vaccine production
TeleTrader 12/12/2022 Amgen to buy Horizon for $26.4 billion
TeleTrader 12/11/2022 Amgen close to buying Horizon, worth over $20B - report
TeleTrader 12/7/2022 Sanofi, GSK surge as court dismisses Zantac suits
TeleTrader 11/10/2022 EU approves Sanofi-GSK booster COVID jab
TeleTrader 10/28/2022 Sanofi: Q3 net sales up 20% to €12.48 billion
TeleTrader 9/5/2022 SocGen CEO to become Sanofi's non-executive chairman
TeleTrader 8/11/2022 GSK falls 12% on worries over Zantac litigation
TeleTrader 7/28/2022 Sanofi's Q2 sales up by 15.7% to €10.12B
TeleTrader 6/24/2022 Sanofi: COVID shot has 72% Omicron efficacy
TeleTrader 6/2/2022 Regeneron to buy Sanofi's stake in joint project for $900M
TeleTrader 4/28/2022 Sanofi's revenue rises 12.6% to €9.7B in Q1
TeleTrader 3/30/2022 EMA begins reviewing Sanofi-GSK COVID-19 vaccine
GlobeNewswire 3/30/2022 Press Release: Availability of the Q1 2022 Memorandum for modelling purposes
GlobeNewswire 3/29/2022 IGM Biosciences Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate...
GlobeNewswire 3/29/2022 IGM Biosciences to Host Conference Call and Webcast Today to Discuss Global Collaboration Agreement ...
GlobeNewswire 3/29/2022 Press Release: Sanofi and IGM Biosciences Announce Collaboration Agreement for Oncology, Immunology ...
GlobeNewswire 3/29/2022 Press Release: Sanofi continues on path to industry leadership in Immunology with Dupixent® (dupilum...
GlobeNewswire 3/28/2022 Press Release: Xenpozyme® (olipudase alfa) approved in Japan, first and only approved therapy indica...
GlobeNewswire 3/26/2022 Press release: Late-breaking Phase 3 data at AAD 2022 show Dupixent® (dupilumab) significantly impro...
GlobeNewswire 3/18/2022 Press Release: Sanofi moves forward with EUROAPI listing on Euronext Paris
GlobeNewswire 3/16/2022 Press Release: Sanofi and Seagen announce collaboration to develop and commercialize multiple novel ...
GlobeNewswire 3/15/2022 Sanofi announces €300 million collaboration with Blackstone Life Sciences to advance an innovative t...